These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 1717384)

  • 1. TRA-1-60: a new serum marker in patients with germ-cell tumors.
    Marrink J; Andrews PW; van Brummen PJ; de Jong HJ; Sleijfer DT; Schraffordt Koops H; Oosterhuis JW
    Int J Cancer; 1991 Sep; 49(3):368-72. PubMed ID: 1717384
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical use of serum TRA-1-60 as tumor marker in patients with germ cell cancer.
    Lajer H; Daugaard G; Andersson AM; Skakkebaek NE
    Int J Cancer; 2002 Jul; 100(2):244-6. PubMed ID: 12115576
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunohistochemical expression of monoclonal antibody 43-9F in testicular germ cell tumours.
    Heidenreich A; Sesterhenn IA; Mostofi FK; Moul JW
    Int J Androl; 1998 Oct; 21(5):283-8. PubMed ID: 9805244
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Importance of a new tumor marker TRA-1-60 in the follow-up of patients with clinical stage I nonseminomatous testicular germ cell tumors.
    Gels ME; Marrink J; Visser P; Sleijfer DT; Droste JH; Hoekstra HJ; Andrews PW; Schraffordt Koops H
    Ann Surg Oncol; 1997 Jun; 4(4):321-7. PubMed ID: 9181232
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The human embryonal carcinoma marker antigen TRA-1-60 is a sialylated keratan sulfate proteoglycan.
    Badcock G; Pigott C; Goepel J; Andrews PW
    Cancer Res; 1999 Sep; 59(18):4715-9. PubMed ID: 10493530
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HLA-antigen distribution in seminoma, HCG-positive seminoma and non-seminomatous tumours of the testis.
    Kratzik C; Aiginger P; Kuzmits R; Spona J; Kirnbauer M; Seiser A; Mayr WR
    Urol Res; 1989; 17(6):377-80. PubMed ID: 2560279
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Profiles of epitope-defined markers in sera from patients with testicular germ cell tumors.
    Yamamoto H; Rudén U; Esposti P; Hirano K; Stigbrand T; Andersson L; Hisazumi H; Wahren B
    Urol Res; 1988; 16(1):31-6. PubMed ID: 2449757
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The value of cancer antigen-125 as a tumor marker in malignant germ cell tumors of the ovary.
    Altaras MM; Goldberg GL; Levin W; Darge L; Bloch B; Smith JA
    Gynecol Oncol; 1986 Oct; 25(2):150-9. PubMed ID: 2428701
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum levels of alpha-fetoprotein, human chorionic gonadotropin and carcinoembryonic antigen in patients with primary intracranial germ cell tumors.
    Arita N; Ushio Y; Hayakawa T; Uozumi T; Watanabe M; Mori T; Mogami H
    Oncodev Biol Med; 1980; 1(4-5):235-40. PubMed ID: 6169060
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Re: tumor marker kinetics predict outcome in patients with relapsed disseminated non-seminomatous germ-cell tumors.
    Richie JP
    J Urol; 2014 Mar; 191(3):659. PubMed ID: 24522037
    [No Abstract]   [Full Text] [Related]  

  • 11. Lectin-reactive alpha-fetoprotein (AFP-L3%) curability and prediction of clinical course after treatment of non-seminomatous germ cell tumors.
    Kamoto T; Satomura S; Yoshiki T; Okada Y; Henmi F; Nishiyama H; Kobayashi T; Terai A; Habuchi T; Ogawa O
    Jpn J Clin Oncol; 2002 Nov; 32(11):472-6. PubMed ID: 12499420
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Retinoic acid-induced differentiation of the developmentally pluripotent human germ cell tumor-derived cell line, NCCIT.
    Damjanov I; Horvat B; Gibas Z
    Lab Invest; 1993 Feb; 68(2):220-32. PubMed ID: 7680083
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of five tumor markers (AFP, CEA, hCG, hPL and SP1) in monitoring therapy and follow-up of patients with testicular germ cell tumors.
    Szymendera JJ; Zborzil J; Sikorowa L; Leńko J; Kamińska JA; Gadek A
    Oncology; 1983; 40(1):1-10. PubMed ID: 6185897
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Use of radioimmunoanalysis for tumor markers in the diagnosis of carcinoma of the testes and prostate].
    Kausitz J
    Bratisl Lek Listy; 1988 Oct; 89(10):715-24. PubMed ID: 2463063
    [No Abstract]   [Full Text] [Related]  

  • 15. Non-seminomatous germ cell tumors of the testis. Analysis of AFP and HCG production by primary tumors and retroperitoneal lymph node metastases after PVB combination chemotherapy.
    Suurmeijer AJ; Oosterhuis JW; Marrink J; De Bruin HW; Schraffordt Koops H; Sleijfer DT; Fleuren GJ
    Oncodev Biol Med; 1983; 4(4):289-308. PubMed ID: 6188132
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictive value of modeled AUC(AFP-hCG), a dynamic kinetic parameter characterizing serum tumor marker decline in patients with nonseminomatous germ cell tumor.
    You B; Fronton L; Boyle H; Droz JP; Girard P; Tranchand B; Ribba B; Tod M; Chabaud S; Coquelin H; Fléchon A
    Urology; 2010 Aug; 76(2):423-9.e2. PubMed ID: 20472276
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunochemical determination of human chorionic gonadotropin and alpha-fetoprotein in sera and tumors of patients with testicular cancer.
    Javadpour N; McIntire KR; Waldmann TA
    Natl Cancer Inst Monogr; 1978 Dec; (49):209-13. PubMed ID: 86162
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Contributions of immunocytochemistry to the diagnosis and study of ovarian neoplasms.
    Kurman RJ; Ganjei P; Nadji M
    Int J Gynecol Pathol; 1984; 3(1):3-26. PubMed ID: 6203854
    [No Abstract]   [Full Text] [Related]  

  • 19. Lectin-reactive alpha-fetoprotein as a marker for testicular tumor activity.
    Kawai K; Kojima T; Miyanaga N; Hattori K; Hinotsu S; Shimazui T; Akaza H
    Int J Urol; 2005 Mar; 12(3):284-9. PubMed ID: 15828957
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Monitoring of patients with non-seminomatous germ cell tumors of the testis by determination of alpha-fetoprotein and beta-human chorionic gonadotropin levels and by computed tomography.
    Kausitz J; Ondrus D; Belan V; Matoska J
    Neoplasma; 1992; 39(6):357-61. PubMed ID: 1283444
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.